Open Accessibility Menu

Women's Health

Breast Cancer

(Integrated Machine Learning to Inform Precision Therapy in Underrepresented Triple Negative Breast Cancer)

Enrollment Complete

This purpose of this study is to better understand the differences in breast cancer found in Hispanic vs. non-Hispanic women and to help match Triple Negative Breast Cancer tumors with cancer therapies. Participants are Hispanic and diagnosed with triple-negative breast cancer.

Primary Investigator: Dr. S. Hasnat Ahmed

You may be eligible if:

Benefits of participating: The knowledge that you are helping others

Participant Details:

  • Eligible individuals are contacted by ECRMC’s Oncology Center. Potential participants will be scheduled to visit the Research Center to complete an informed consent document and have blood specimens collected. Previously collected and stored breast tissue will be submitted for further study.

For more information visit: